ArticleCNS neuroscience & therapeutics2026
Comprehensive Evaluation of YJ-2 as a PAD4 Inhibitor in Alleviating Ischemic Brain Injury: From NETs-Induced Neurotoxicity to In Vivo Neuroprotection.
Yijiang Jia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.